The clinical information analysis indicated that HSPB6 expression was negatively correlated with Gleason score, T classification, lymph node metastasis, and distant metastasis, highlighting its significance as a clinical indicator (Table 1). This evidence concerns the gene HSPB6 and metastatic malignant neoplasm in the lymph nodes.